Pharmacoeconomic aspects of inhaled corticocteroids in the treatment of asthma

O. P. Pashchenko, B. I. Geltser, T. N. Sourovenko, E. A. Kochetkova (Vladivostok, Russia)

Source: Annual Congress 2001 - Inhaled corticosteroids
Session: Inhaled corticosteroids
Session type: Thematic Poster Session
Number: 697
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. P. Pashchenko, B. I. Geltser, T. N. Sourovenko, E. A. Kochetkova (Vladivostok, Russia). Pharmacoeconomic aspects of inhaled corticocteroids in the treatment of asthma. Eur Respir J 2001; 16: Suppl. 31, 697

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparative studies of inhaled corticosteroids in asthma
Source: Eur Respir J 2001; 17: 579-580
Year: 2001


Clinical evolution of potroom asthma - effects of introducing montelukast to standard treatment with corticosteroid and beta-agonists
Source: Eur Respir J 2001; 18: Suppl. 33, 278s
Year: 2001

An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019

Determinants of adherence to inhaled corticosteroids in children with asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010


The role of inhaled corticosteroids in the management of acute asthma
Source: Eur Respir J 2007; 30: 1035-1037
Year: 2007


Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020


Measures to assess adherence to inhaled corticosteroids for asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 294s
Year: 2003

Considerations about cost-effectiveness and global satisfaction of asthmatic patients treated with montelukast compared with inhaled corticosteroids
Source: Eur Respir J 2002; 20: Suppl. 38, 42s
Year: 2002

Efficacy and safety of high-dose inhaled corticosteroids therapy in children with asthma
Source: Annual Congress 2010 - Allergy and risk factors in paediatrics
Year: 2010


Regular use of inhaled corticosteroids and the long-term prevention of hospitalisation for asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 8s
Year: 2002

Estimate of asthma control and adherence to inhaled corticosteroids in children with asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010


Meta-analysis of inhaled corticosteroids response in children with asthma.
Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics
Year: 2019


Inhaled corticosteroids in the treatment of acute asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002

Control of persistent asthma patients on inhaled corticosteroids in a real-life setting
Source: Annual Congress 2010 - New insights in the epidemiology of asthma
Year: 2010


Efficacy of inhaled ciclesonide compared with oral prednisolone in the treatment of asthma exacerbations
Source: Eur Respir J 2006; 28: Suppl. 50, 206s
Year: 2006

Pharmacogenetics of inhaled corticosteroid response in adults with asthma
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020




Cost of asthma rescue/acute and allergy medications among asthmatic patients on controller therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 344s
Year: 2004

Long-term treatment of aspirin-intolerante asthma with budesonide. Effectivity and safety
Source: Eur Respir J 2001; 18: Suppl. 33, 156s
Year: 2001

Effects of inhaled corticosteroids on cough in asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Year: 2004